Inovio Pharma gets green signal to test Zika vaccine in human trial

By: |
June 20, 2016 5:37 PM

Drug developer Inovio Pharmaceuticals Inc and its partner GeneOne Life Sciences Inc said they had received approval from U.S. regulators to start an early stage human trial testing their Zika vaccine.

The early-stage study will enroll 40 healthy subjects and evaluate safety, tolerability and immune response generated by the vaccine GLS-5700 (Reuters)The early-stage study will enroll 40 healthy subjects and evaluate safety, tolerability and immune response generated by the vaccine GLS-5700 (Reuters)

Drug developer Inovio Pharmaceuticals Inc and its partner GeneOne Life Sciences Inc said they had received approval from U.S. regulators to start an early stage human trial testing their Zika vaccine.

The early-stage study will enroll 40 healthy subjects and evaluate safety, tolerability and immune response generated by the vaccine GLS-5700.

“We plan to dose our first subjects in the next weeks and expect to report phase I interim results later this year,” Inovio CEO J Joseph Kim said.

In February, the World Health Organization (WHO) declared Zika a global public health emergency. The virus has been associated with microcephaly, a birth defect characterized by an unusually small head and potential developmental problems.

Last week, U.S. health officials reported three babies born with birth defects likely linked to Zika infection in the mother during pregnancy.

French drugmaker Sanofi SA is likely to begin testing its own vaccine in humans next year.
India’s Bharat Biotech is another company that is in the race to develop a vaccine for the mosquito-borne disease.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Gross inequity in vaccine access hurting; China way ahead, says WHO’s Dr Soumya Swaminathan
2Travel rebound: 2 million people go through US airports
3Delhi weather update: Maximum temperature settles at 34.4 degrees Celsius in national capital, humidity 50 pc